AIM IMMUNOTECH INC.
Income Statement
| Line Item | FY2010 | FY2009 |
|---|---|---|
| Revenue | $135.0K | $111.0K |
| Cost of Revenue | $1.3M | $584.0K |
| Gross Profit | $-1.2M | $-473.0K |
| Gross Margin | -893.3% | -426.1% |
| Operating Expenses | ||
| Research & Development | $7.6M | $7.0M |
| SG&A Expense | $7.6M | $5.8M |
| Operating Income | $-16.4M | $-13.3M |
| Operating Margin | -12,138.5% | -11,949.5% |
| Interest Expense | $11.0K | $0 |
| Pretax Income | — | — |
| Income Tax Expense | — | — |
| Net Income | $-13.1M | $-7.2M |
| Net Margin | -9,730.4% | -6,468.5% |
| EPS (Basic) | $-0.03 | $-0.02 |
| EPS (Diluted) | $-0.03 | $-0.02 |
| Shares Outstanding (Basic) | 405.7M | — |
| Shares Outstanding (Diluted) | 405.7M | — |
| Dividends Per Share | — | — |